Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Pollastri

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
European Journal of Medicinal Chemistry|May 14, 2018
Corrigendum to "Optimization of physicochemical properties for 4-Anilinoquinazoline inhibitors of trypanosome proliferation" [Eur. J. Med. Chem. 141 (2017) 446-459]Jennifer L Woodring, Kelly A Bachovchin, Kimberly G Brady, et al.
Journal of the American Society of Nephrology : JASN|May 29, 2015
The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in UremiaSowmya Shivanna, Kumaran Kolandaivelu, Moshe Shashar, et al.
Journal of Medicinal Chemistry|March 2, 2013
Antitrypanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growthGrasiella Andriani, Emanuele Amata, Joel Beatty, et al.
ACS Infectious Diseases|January 24, 2017
From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African TrypanosomiasisWilliam G Devine, Rosario Diaz-Gonzalez, Gloria Ceballos-Perez, et al.
Journal of Medicinal Chemistry|June 19, 2015
Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead DiscoveryWilliam Devine, Jennifer L Woodring, Uma Swaminathan, et al.
Plos One|February 6, 2014
Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 productionMargaret M Lowe, Jeff E Mold, Bittoo Kanwar, et al.
ACS Infectious Diseases|March 22, 2016
Identification of "Preferred" Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing?Emanuele Amata, Hualin Xi, Gonzalo Colmenarejo, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Structure-Bioactivity Relationships of Lapatinib Derived Analogs against <i>Schistosoma mansoni</i>Melissa J Buskes, Monica Clements, Kelly A Bachovchin, et al.
ACS Medicinal Chemistry Letters|October 23, 2018
Series of Alkynyl-Substituted Thienopyrimidines as Inhibitors of Protozoan Parasite ProliferationJennifer L Woodring, Ranjan Behera, Amrita Sharma, et al.
Journal of Medicinal Chemistry|January 25, 2023
Chemical Optimization of CBL0137 for Human African Trypanosomiasis Lead Drug DiscoveryBaljinder Singh, Amrita Sharma, Naresh Gunaganti, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Medicinal Chemistry|May 14, 2018
Corrigendum to "Optimization of physicochemical properties for 4-Anilinoquinazoline inhibitors of trypanosome proliferation" [Eur. J. Med. Chem. 141 (2017) 446-459]Jennifer L Woodring, Kelly A Bachovchin, Kimberly G Brady, et al.
Journal of the American Society of Nephrology : JASN|May 29, 2015
The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in UremiaSowmya Shivanna, Kumaran Kolandaivelu, Moshe Shashar, et al.
Journal of Medicinal Chemistry|March 2, 2013
Antitrypanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growthGrasiella Andriani, Emanuele Amata, Joel Beatty, et al.
ACS Infectious Diseases|January 24, 2017
From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African TrypanosomiasisWilliam G Devine, Rosario Diaz-Gonzalez, Gloria Ceballos-Perez, et al.
Journal of Medicinal Chemistry|June 19, 2015
Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead DiscoveryWilliam Devine, Jennifer L Woodring, Uma Swaminathan, et al.
Plos One|February 6, 2014
Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 productionMargaret M Lowe, Jeff E Mold, Bittoo Kanwar, et al.
ACS Infectious Diseases|March 22, 2016
Identification of "Preferred" Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing?Emanuele Amata, Hualin Xi, Gonzalo Colmenarejo, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Structure-Bioactivity Relationships of Lapatinib Derived Analogs against <i>Schistosoma mansoni</i>Melissa J Buskes, Monica Clements, Kelly A Bachovchin, et al.
ACS Medicinal Chemistry Letters|October 23, 2018
Series of Alkynyl-Substituted Thienopyrimidines as Inhibitors of Protozoan Parasite ProliferationJennifer L Woodring, Ranjan Behera, Amrita Sharma, et al.
Journal of Medicinal Chemistry|January 25, 2023
Chemical Optimization of CBL0137 for Human African Trypanosomiasis Lead Drug DiscoveryBaljinder Singh, Amrita Sharma, Naresh Gunaganti, et al.
Pageof 7